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Abstract In cultured human fibroblasts the transport of anionic amino acids through the sodium-dependent system Xi, is stimulated rapidly and 
transiently by phorbol 12,13-dibutyrate. Transport stimulation is consistent with an effect due to the activation of protein kinase C. Bradykinin 
(1 PM) and PDGF-AA (100 &ml) also stimulate the activity of system Xi,. The bradykinin effect appears to be fully dependent upon PKC activation 
whereas the stimulation of aspartate transport by PDGF-AA is also due to PKC-independent mechanisms. 
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1. Introduction 
System Xi, is a Na’-dependent, high-affinity transport 
agency for L-aspartate and L-glutamate operative in mesenchy- 
ma1 cells [l-3]; the system is sensitive to membrane potential 
[4] and interacts efficiently with p-aspartate but not with 
n-glutamate [I]. Results from our group have indicated that 
phorbol esters stimulate the Na’-dependent transport of ani- 
onic amino acids through system Xi, in cultured human fi- 
broblasts [S]. However, preliminary observations from other 
authors have not confirmed this finding [6]. In this report we 
have further characterized the effect of phorbol esters on the 
activity of system X,& and demonstrate here that the transport 
enhancement is fully consistent with an effect mediated by PKC 
activation. Other activators of PKC have been also evaluated 
in the attempt to assess whether the stimulation of anionic 
amino acid transport can be considered an effect of physiolog- 
ical PKC activation. 
2. Materials and methods 
Human foreskin fibroblasts were derived from a 15-year-old onor. 
Cells were routinely grown in DMEM supplemented with 10% FBS. All 
measurements were made with subcultures resulting from 5.104 cells 
seeded into 2-cm2 wells of disposable 24-well multidish trays (Nunc) 
and grown for 3 days. Unless otherwise stated, the growth medium was 
replaced with DMEM containing 0.5% FBS on the day before the 
experiment. The treatment with PDBu and the other compounds was 
carried out in this medium. After the treatments pecified for each 
experiment, the transport activity of system Xi, was evaluated, as 
described [7], by measuring the initial velocity of entry of [‘H]L-aspar- 
tate (10 PM; 3 &i/ml) over I-min periods in the same conditions 
adopted for cell culture. At the concentration employed for the assay 
L-aspartate is a specific substrate of system Xi, [1,2]. The experiments 
were stopped with three rapid washes in 3 ml ice-cold 0.1 M MgCl,; 
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ethanol extracts of cells were added to 2.5 ml of scintillation fluid and 
counted for radioactivity with a Packard 460 liquid scintillation spec- 
trometer. Cell monolayers were then dissolved with 0.5% sodium de- 
oxycholate in 1 M NaOH and protein content was determined using 
a modified Lowry procedure, as described [7]. 
For PDBu binding assay, human fibroblasts were washed five times 
with DMEM and then incubated for 30 min in ice-cold EBSS in the 
presence of increasing concentrations of [3H]PDBu (2.5-200 nM; 
0.054~Cilml). Non-specific [‘H]PDBu binding was assessed in parallel 
cultures incubated in the presence of 10 PM unlabelled PDBu and the 
specific binding was calculated by difference. At the end of incubation 
fibroblasts were washed six times with 0.1 M MgCI, and extracted with 
0.2 ml ethanol; cell extracts were added to 2.5 ml of scintillation fluid 
and counted for radioactivity. The estimation of binding parameters 
was performed with a non-linear egression analysis of specific binding 
data following the equation 
B 
B= 
mar .F’DW 
KS + [PDBu] (1) 
Membrane potential has been monitored from the tram- membrane 
distribution ratio of L-arginine, employed as an indicator of membrane 
potential [8,9], following the equation 
RT [Arglin 
A’ = 7 In [Arg],,, 
To calculate the intracellular concentration of arginine, the cell water 
content was calculated from the difference between total water (urea 
space) and extracellular fluid (inuhn space) determined according to the 
procedure described by Dall’Asta et al. [9]. 
Fetal bovine serum (FBS) and growth medium (Dulbecco’s modified 
Eagle medium, DMEM) were from Gibco. Sphingosine and stauro- 
sporine were purchased from Boeringher. L-[2,3- ‘H]Aspartic acid (13.5 
Wmmol), L-[2,3-3H]arginine (55 Ci/ mmol), [14C]urea (4.2 Wmmol), 
[methoxy-‘Hlinulin (355 mCi/ g), and [20-3H(N)]phorbol 12,13-dibu- 
tyrate ([‘H]PDBu, 20 Gil mmol) were obtained from New England 
Nuclear. The source of all other chemicals was Sigma. 
3. Results 
The initial velocity of L-aspartate ntry into cultured human 
fibroblasts was increased after incubation in the presence of 
PDBu (Fig. 1). The time course of the effect indicates that the 
maximal stimulation was reached after a 15-min incubation and 
decreased thereafter. After 12 h of incubation in the presence 
of PDBu aspartate transport had returned to basal values. 
4c+PDD, a phorbol ester that not activates PKC [lo], had no 
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Fig. 1. Effect of PDBu on the transport of L-aspartate in cultured 
human fibroblasts. The uptake of L-aspartate (assay time 1 min) was 
determined after the indicated times of pre-incubation in the presence 
of 100 nM PDBu (0) or 4cc-PDD (0). Note that pre-incubation in the 
presence of 100 nM 4a-PDD had no effect on L-aspartate uptake, as 
compared to the untreated controls (0 min pre-incubation). Means of 
five independent determinations are shown with S.D. indicated. 
effect on aspartate transport. Stimulatory effects were also de- 
tected after 15-min treatment with 100 nM PMA or with the 
cell-permeable diacylglycerol DiC, [ 111, employed at a concen- 
tration of 200 PM, but not with DiC,,, a cell impermeable 
diacylglycerol [ 121 (not shown). 
Fig. 2 (left panel) shows that a 24-hour incubation of cultured 
human fibroblasts in a medium supplemented with 1 ,uM PDBu 
(a treatment associated with down-regulation of PKC [13]) 
markedly depressed the specific binding of labelled PDBu 
(&,x = 0.438 + 0.115 VS. 2.19 f. 0.325 pmollmg protein in un- 
treated cells). After a prolonged treatment with phorbol esters, 
the transport of aspartate was substantially comparable to that 
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Table 1 
Stimulation of L-aspartate transport of bradykinin: effects of PDBu and 
staurosporine 
V (pmoUmg prot/min) Stimulation P* 
-BK +BK (%) 
None 58 f 5.1 83 f 3.2 43 < 0.005 
SSP 71 f 4.9 70f 1.7 - n.s. 
PDBu 15 min 144 f 2.2 14Of8.5 - n.s. 
PDBu 24 h 59 f 3.0 62 f. 3.2 5 n.s. 
Cells were treated, as indicated, with BK (1 PM; 10 min), SSP (100 nM; 
20 min), PDBu (100 nM; 15 min or 24 h) before the uptake assay. The 
results are means of three independent determinations with S.D. indi- 
cated, the level of significance was assessed with a two-tail r-test for 
unpaired data. 
*Treated with growth factor vs. untreated. 
observed in untreated cells. However, the down-regulation of 
PDBu binding sites completely abolished the short-term stimu- 
lation of aspartate transport by a subsequent treatment with 
phorbol esters (right panel). 
At concentrations of 50 nM or higher, the PKC inhibitor 
staurosporine completely suppressed the stimulatory effect of 
PDBu on aspartate transport (Fig. 3). The inhibitor selectively 
affected the PDBu-stimulated portion of aspartate transport; 
in the absence of the phorbol ester the transport of the amino 
acid was rather slightly stimulated by staurosporine. A 60% 
inhibition of PDBu-stimulated aspartate transport was also 
obtained with sphingosine, another PKC inhibitor, employed 
at 5 PM (not shown). 
Since the activity of system Xi, is dependent on membrane 
potential [5,14], the effect of phorbols on membrane potential 
was investigated. In cultured human fibroblasts PDBu caused 
a marked and prolonged depolarization of cell membrane while 
the inactive phorbol ester 4u-PDD had no effect on the mem- 
brane potential (Fig. 4). 
Growth factors that stimulate phosphatidylinositols hydroly- 
sis and activate PKC (PDGF-AA and BB, bradykinin) were 
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Fig. 2. Down-regulation of PDBu binding and loss of PDBu-dependent stimulation of L-aspartate transport after prolonged exposure of cultured 
human fibroblasts to PDBu. (Left) Cultured human fibroblasts were incubated for 24 h in DMEM supplemented with 0.5% FBS in the absence (0) 
or in the presence (0) of 1 PM PDBu. The specific binding of [‘H]PDBu was then determined as described in section 2. Lines represent non-linear 
regression of experimental points to Eqn. 1 of section 2. (Right) The cells were pre-incubated for 24 h in the absence (empty bars) or in the presence 
(solid bars) of 1 PM PDBu. L-Aspartate transport was measured after a further 15-min incubation in the presence of the indicated concentrations 
of PDBu. The results are means of three independent determinations with S.D. indicated. 
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Fig. 3. Inhibition of the PDBu-induced stimulation of L-aspartate trans- 
port by staurosporine. L-Aspartate transport was measured after a 
20-min pre-incubation in the presence of the indicated concentrations 
of staurosporine; the last 15 min of incubation were performed in the 
absence (0) or in the presence (0) of 100 nM PDBu. Data are means 
of three independent determinations with S.D. indicated. 
tested to observe their effects on aspartate transport. Each 
factor was tested at increasing concentrations for various times 
of incubation. Both BK and PDGF-AA significantly stimulated 
transport activity for L-aspartate, although with different time 
courses. For BK the maximal stimulation was detected at 10 
min with a concentration of 1 PM; with PDGF-AA the stimu- 
lation was maximal at 100 ng/ml after 2 min of incubation and 
decreased rapidly thereafter. PDGF-BB did not significantly 
stimulate the activity of system Xi,. The stimulatory effects of 
bradykinin and PDGF-AA were studied in control, untreated 
cells or in cells incubated with either PDBu (after both short- 
term and long-term treatments) or staurosporine. The results 
indicate that the effect of BK (Table 1) was suppressed by 
staurosporine, not additive to that of PDBu and hindered by 
the down-regulation of PKC, caused by chronic PDBu treat- 
ment. Although not significantly additive to the effect of PDBu, 
the stimulation of L-aspartate transport by PDGF-AA (Table 
2) was neither completely inhibited by staurosporine nor fully 
suppressed by PKC down-regulation. 
Table 2 
Stimulation of L-aspartate transport by PDGF-AA: Effects of PDBu 
and staurosporine 
V (pmol/mg prot/min) Stimulation P* 
- PDGF- + PDGF- (%) 
AA AA 
None 65 f 3.0 102 f0.6 57 < 0.002 
SSP 73 f 5.2 90 + 6.0 23 < 0.05 
PDBu 15 min 146 f 4.7 161 f 10.2 10 ns. 
PDBu 24 h 71 f 4.5 86kO.7 21 < 0.05 
Cells were treated, as indicated, with PDGF-AA (100 r&ml; 2 min), 
SSP (100 nM; 20 min), PDBu (100 nM; 15 min or 24 h) before the 
uptake assay. The results are means of three independent determina- 
tions with S.D. indicated; the level of significance was assessed with a 
two-tail t-test for unpaired data. 
*Treated with growth factor vs. untreated. 
4. Discussion 
The results presented here indicate that the stimulation of 
anionic amino acid transport through system Xi, is a short- 
term effect of PKC activation in cultured human fibroblasts. 
It should be stressed that this effect is also detectable with 
physiological activators of PKC; moreover, the assay of aspar- 
tate transport has been performed under conditions similar to 
those employed for the cultivation of these cells. PDBu effect 
is rapid and transient; after a 24 h treatment (i.e. under Balcar 
et al.‘s conditions [6]) no stimulation of aspartate transport is 
detectable, most probably because of PKC down regulation. 
PKC activation depolarizes human fibroblasts (Fig. 4); this 
result indicates that the PKC-dependent enhancement of aspar- 
tate transport is not due to an increase in the driving force for 
transport contributed by membrane potential. The independ- 
ence from membrane potential changes, the rapid onset of the 
effect (this paper) and the absence of requirement for an active 
protein synthesis [5] would suggest hat also in cultured human 
fibroblasts PKC stimulates aspartate transport through a direct 
interaction with the transporter, as recently described for rat 
glia [15]. Consensus sites for PKC are indeed present in the 
cytoplasmic portions of all the predicted models of high affin- 
ity, Na’-dependent glutamate transporters cloned thus far [ 161. 
BK stimulation appears to be only dependent upon PKC 
activation, in agreement with the information available about 
signal transduction through BK receptor [17]. On the other 
hand, PKC activation does not entirely account for the stimu- 
lation of system Xi, activity due to PDGF-AA, that is only 
partially inhibited by PKC down-regulation and staurosporine. 
PDGF-AA interacts with and activates a subtype of PDGF 
receptor, which represents a minority of the total number of 
PDGF receptors of cultured human fibroblasts [ 181. However, 
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Fig. 4. Effect of phorbol esters on membrane potential of cultured 
human fibroblasts. Cultured human fibroblasts were incubated for 
6 h in DMEM supplemented with FBS (0.5%) and deprived of 
L-arginine and L-lysine. In the last 90 min of pre-incubation the medium 
was replaced by DMEM containing [‘H]L-arginine (0.02 mM, 1 pCi/ 
ml). At the end of this period, the incubation was prolonged for 30 min 
in the same medium in the absence (0, control) or in the presence of 
100 nM PDBu (0) or 100 nM a-PDD (0). Cell content of arginine was 
determined at the indicated times. Membrane potential was determined 
as described in section 2 according to Eqn. 2. Data are means of three 
independent determinations with S.D. indicated. 
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this PDGF isoform is a more potent PKC activator than BB 
and AB isoforms in models other than human fibroblasts [19]. 
In various biological models the activation of PDGF receptors 
is linked not only to PKC activation but also triggers other 
signal transduction pathways, such as CAMP production [20] 
and PLC-y activation [21]. It is therefore possible that one of 
these additional transduction pathways accounts for the PKC- 
independent stimulation of aspartate transport since, besides 
PKC consensus sequences, also a PKA consensus motif ap- 
pears in the sequence of the cloned high-affinity glutamate 
transporters [22]. However, in our hands, PKA activation with 
theophylline and 8-Br-CAMP has failed to cause significant 
changes in aspartate transport (Franchi-Gazzola and Visigalli, 
unpublished observation). 
In contrast to the stimulation of aspartate transport observed 
here in PDBu-treated cultured human fibroblasts, the treat- 
ment with the phorbol ester is associated with a slow, progres- 
sive decrease of system Xi, activity in NIH3T3 cells [23]. This 
discrepancy could be referred either to different PKC isoen- 
zymes or to different Xi, carrier subtypes. The former possibil- 
ity agrees with available data [24-261 and would suggest hat 
the stimulation of anionic amino acid transport constitutes an 
effect due to the activation of specific PKC isoenzymes. 
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